Navy Medicine Research and Development Enterprise Logo, provided via NMRC.
SILVER SPRING, Md. — The Naval Medical Research Center (NMRC) held the Research and Development Enterprise Commander’s Conference, May 4-5, 2017. The conference provided an opportunity for the laboratory leadership to discuss success, challenges and future goals. .
The enterprise includes eight laboratories, NMRC, Naval Health Research Center, Naval Submarine Medical Research Laboratory, Naval Medical Research Unit – San Antonio, Naval Medical Research Unit – Dayton, U.S. Naval Medical Research Center – Asia, U.S. Naval Medical Research Unit No. 3 Cairo, and U.S. Naval Medical Research Unit No. 6 Peru.
In attendance were the commanding officers and executive officers for each laboratory, science directors and comptrollers, as well as representatives from the Bureau of Medicine and Surgery, and Rear Admiral Paul D. Pearigen, commander, Navy Medicine West.
“I really want each of you to use this time to reflect on each of your commands major successes, the research conducted, and how we can further our goals and continue to make an impact on the challenges that the warfighter faces,” said Capt. Adam Armstrong, commanding officer, NMRC.
Progress was made, thoughts were shared, and steps were taken in a positive direction by all commands in attendance. Pearigen ended the two day conference with a note of appreciation for the hard work being conducted in Navy Medicine’s research and development laboratories, “as you all move forward with your goals and tackle the issues you face, I look forward to seeing the work that is done and am here to assist you in meeting your goals to provide for the warfighter.”
Navy Medicine's research and development laboratories are engaged in a broad spectrum of activity from basic science in the laboratory to field studies at sites in remote areas of the world to operational environments. The capabilities and the geographical locations of the laboratories reflect the broad mission of Navy Medicine's Research and Development enterprise. With a cadre of scientific leadership and technical expertise focusing on force health protection and enhancing deployment readiness, the research teams represent years of experience in science, medicine and the military.
In support of the Navy, Marine Corps, and joint U.S. warfighters, researchers study infectious diseases; biological warfare detection and defense; combat casualty care; environment health concerns; bone marrow research and registry; aerospace and undersea medicine; medical modeling, simulation and operational mission support; and epidemiology and behavioral sciences.
The goal is to deliver high-value, high-impact research products to support and protect today's deployed warfighters. At the same time researchers are looking to the readiness and well-being of future forces.